You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Steroid resistant

Showing 1 - 25 of 7,399
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 27, 2022

Immune Thrombocytopenia Trial in Beijing (TAC, Danazol)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jul 20, 2022

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG [Olumiant], Danazol)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
  • +9 more
May 2, 2023

Immune Thrombocytopenia Trial in Beijing (Iguratimod)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 21, 2022

Nephrotic Syndrome Trial in Kolkata (Rituximab, Tacrolimus)

Recruiting
  • Nephrotic Syndrome
  • Kolkata, West Bengal, India
    NRS Medical College & Hospital
Apr 6, 2022

Immune Thrombocytopenia, Blood Coagulation Disorders, Thrombocytopenia Trial in Beijing (Sitagliptin, Danazol)

Recruiting
  • Immune Thrombocytopenia
  • +3 more
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 25, 2022

Safety and Efficacy Trial in Suzhou (Chidamide)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    First Affiliated Hospital,Soochow University
Nov 30, 2021

ITP, Immune Thrombocytopenia Trial in Beijing (Iguratimod, Danazol)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, China
  • +1 more
Apr 29, 2022

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023

Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)

Not yet recruiting
  • Purpura, Thrombocytopenic, Idiopathic
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jun 25, 2022

Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem

Recruiting
  • Graft-versus-host Disease
  • +2 more
  • Mesenchymal stem cells
  • Edeghem, Antwerpen, Belgium
  • +11 more
Sep 19, 2022

Pericarditis Trial (Anakinra, Prednisone)

Not yet recruiting
  • Pericarditis
  • (no location specified)
Apr 6, 2023

Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in New Hyde Park, Philadelphia

Recruiting
  • Nephrotic Syndrome in Children
  • +2 more
  • trascutaneous auricular vagus nerve stimulation
  • Sham device
  • New Hyde Park, New York
  • +1 more
Dec 19, 2022

Safety and Efficacy Trial in Suzhou (Ruxolitinib)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 23, 2021

Steroid Resistant Acute GVHD Trial in Lyon (inolimomab)

Available
  • Steroid Resistant Acute Graft Versus Host Disease
  • inolimomab
  • Lyon, France
    ElsaLys Biotech
Sep 16, 2021

Acute GVHD, Gastrointestinal Tract Acute GVHD, Severe Gastrointestinal Tract Acute GVHD Trial in Los Angeles (Fecal Microbiota

Not yet recruiting
  • Acute Graft Versus Host Disease
  • +3 more
  • Fecal Microbiota Transplantation Capsule
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 16, 2022

Alport Syndrome, Focal Segmental Glomerulosclerosis Trial in United States (R3R01)

Recruiting
  • Alport Syndrome
  • Focal Segmental Glomerulosclerosis
  • Los Angeles, California
  • +10 more
Aug 15, 2022

Graft Vs Host Disease Trial in Toronto (Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP),

Recruiting
  • Graft Vs Host Disease
  • Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP), mTOR inhibitors (everolimus or sirolimus), vedolizumab, ruxolitinib.
  • Decidual Stromal Cells
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 3, 2022

Combination Acthar Gel and Tacrolimus in Treatment of Steroid

Suspended
  • Nephrotic Syndrome
  • Acthar Gel and Tacrolimus
  • Chattanooga, Tennessee
    Nephronet
Feb 15, 2021

Graft Vs Host Disease Trial in Beijing (UC-MSC, Anti-CD25 mAb)

Not yet recruiting
  • Graft Vs Host Disease
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Feb 1, 2021

Immune Thrombocytopenia Trial in Beijing (Rituximab, All-trans retinoic acid)

Active, not recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
  • +3 more
Jan 16, 2021

Primary Immune Thrombocytopenia Trial in Guadalajara (Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet)

Completed
  • Primary Immune Thrombocytopenia
  • Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Sep 20, 2022

Graft Vs Host Disease Trial in United States (ALPN-101)

Terminated
  • Graft Vs Host Disease
  • Miami, Florida
  • +3 more
Aug 24, 2020

Ophthalmopathy, Thyroid-Associated Trial in Gothenburg, Mölndal, Stockholm (Rituximab, Iv Methylprednisolone, peroral

Active, not recruiting
  • Ophthalmopathy, Thyroid-Associated
  • Gothenburg, Sweden
  • +4 more
Sep 17, 2021

GVHD Trial in Australia, United Kingdom (Mesenchymoangioblast-derived mesenchymal stem cells)

Completed
  • Graft vs Host Disease
  • Mesenchymoangioblast-derived mesenchymal stem cells
  • Sydney, New South Wales, Australia
  • +6 more
Aug 8, 2020